Data from First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma
2024 · 0 citations
https://doi.org/10.1158/2159-8290.c.7022624
L
Lindsey Granlund
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
131
Citations
3
h-index
2
i10-index
Lindsey Granlund is an academic researcher. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Chronic Myeloid Leukemia Treatments & Lymphoma Diagnosis and Treatment. The author has an h-index of 3, co-authored 7 publications.
ORCID: 0009-0000-9098-2324Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat